doi:10.3969/j.issn.1673-8640.2020.10.025

Abstract

CLC Number:

R373.1

References 8

[1]	国家卫生健康委办公厅,国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL]. (2020-03-03)[2020-03-04]. .
[2]	国家卫生健康委员会. 新型冠状病毒感染的肺炎实验室检测技术指南(第二版) [EB/OL]. (2020-01-22)[2020-03-04]. .
[3]	国家卫生健康委办公厅. 新型冠状病毒肺炎防控方案(第五版)[EB/OL]. (2020-02-21)[2020-03-04]. .
[4]	WANG D,HU B,HU C,et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,China[J]. JAMA,2020,323(11):1061-1069.
[5]	YAN R,ZHANG Y,LI Y,et al.Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2[J]. Science,2020,367(6485):1444-1448.
[6]	HAMMING I,TIMENS W,BULTHUIS M L,et al.Tissue distribution of ACE2 protein,the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis[J]. J Pathol,2004,203(2):631-637.
[7]	李金明. 我国临床分子诊断试剂发展:问题及思考[J]. 检验医学,2014,29(3):199-201.
[8]	中华医学会检验分会. 2019新型冠状病毒肺炎临床实验室检测的生物安全防护指南(试行第一版)[Z]. 2020.

[1]	CHEN Danyang, ZHENG Siyu, ZHENG Ruilin, SU Jingyao, ZHU Bing, LI Yinghua. Research progress in influenza viruses [J]. Laboratory Medicine, 2023, 38(7): 696-703.
[2]	XIAO Xiumei, LIANG Chao, LIU Caihong, LI Xiaoguang. Comparison of SARS-CoV-2 neutralizing antibody and specific antibody determination results [J]. Laboratory Medicine, 2023, 38(4): 352-356.
[3]	ZENG Yanfen, WU Quanming, ZHOU Huan, ZHANG Qiuqin, KANG Yanli, LI Yao, CHEN Xijun, HUANG Jiangang, CHEN Falin. Determination limits of a severe acute respiratory syndrome coronavirus 2 nucleic acid determination reagent in 4 determination systems [J]. Laboratory Medicine, 2023, 38(3): 261-266.
[4]	WEI Rui, YUAN Xu, TIAN Xuewen, LU Yanjun. Clinical and laboratory characteristics of human metapneumovirus infection children in a Grade A Class 3 hospital in Wuhan [J]. Laboratory Medicine, 2023, 38(1): 18-22.
[5]	YANG Danping, WANG Hong, WANG Can, CHEN Wei, YANG Aiping. Diagnostic efficacy and clinical application evaluation of SARS-CoV-2 antigen determination [J]. Laboratory Medicine, 2023, 38(1): 28-31.
[6]	. [J]. Laboratory Medicine, 2023, 38(1): 76-77.
[7]	YUE Caidie, LI Junyan, DING Aijun, XIE Li, ZENG Weikun. Research progress of rapid determination methods for SARS-CoV-2 antigen [J]. Laboratory Medicine, 2023, 38(1): 87-93.
[8]	FANG Huiling, CHEN Ziqi, ZHU Yuqing. Performance of antigen test for SARS-CoV-2 and related research progress [J]. Laboratory Medicine, 2022, 37(11): 1098-1103.
[9]	. [J]. Laboratory Medicine, 2022, 37(9): 868-871.
[10]	LI Cheng, ZHOU Min, LEI Boya, CHANG Qing, CAO Wenjun, WANG Zhujian. Role of VZV DNA and IgG antibody determinations in aqueous humor of ARN patients in evaluation of antiviral efficacy [J]. Laboratory Medicine, 2022, 37(9): 831-834.
[11]	CHEN Qian, SHAN Zhiming, SONG Chao, KANG Fengfeng, JIN Jing, LI Weixing. Status of quality management of new laboratories for nucleic acid determination of SARS-CoV-2 in Zhejiang [J]. Laboratory Medicine, 2022, 37(7): 669-673.
[12]	WANG Xiaoyu, SEMIRE Ainiwaer, LI Shijun. Influence of specimen state on the accuracy of plasma Epstein-Barr virus DNA determination results [J]. Laboratory Medicine, 2022, 37(7): 615-617.
[13]	HUANG Yao, ZHANG Xiuling, WANG Yan, KONG Guimei, XU Qin. Respiratory tract virus surveillance and analysis of pneumonia inpatients from 2017 to 2020 in Yangzhou [J]. Laboratory Medicine, 2021, 36(11): 1135-1139.
[14]	SHAN Jiani, WANG Tianlin, ZHAO Shuiai, FAN Liyun, LIU Lei. Comparison on the determination rates of respiratory virus antigens between nasopharyngeal swabs and oropharyngeal swabs [J]. Laboratory Medicine, 2021, 36(7): 719-721.
[15]	LIU Shiyun, TAN Ping. Etiological analysis of influenza surveillance in Chizhou from 2018 to 2019 [J]. Laboratory Medicine, 2021, 36(7): 722-725.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 8

Related Articles 15

Recommended Articles

Metrics